Norathyriol suppresses transformation in JB6 P+ cells by the inhibition of Akt

J Cancer Res Ther. 2012 Oct-Dec;8(4):561-4. doi: 10.4103/0973-1482.106537.

Abstract

Context: Chemoprevention has been acknowledged as an important and practical strategy for the management of skin cancer. Norathyriol, a naturally occurring compound present in various plants, has a potent anticancer-promoting activity.

Aims: The aim was to investigate the chemopreventive activity of norathyriol on JB6 P+ cells.

Materials and methods: A soft agar assay was used to detect the effect of norathyriol on cell transformation. The activator protein-1 (AP-1) transactivation activity was examined by the luciferase assay.

Results: Norathyriol inhibited epidermal growth factor (EGF)- and 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced neoplastic cell transformation in a dose-dependent manner. The activation of activator protein-1 was dose dependently suppressed by norathyriol treatment. Western blot data revealed that norathyriol attenuated the phosphorylation of Akt.

Conclusions: Norathyriol exerts a potent chemopreventive activity by inhibiting Akt activation in neoplastic cell transformation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antineoplastic Agents, Phytogenic / pharmacology*
  • Cell Line
  • Cell Transformation, Neoplastic / drug effects*
  • Cell Transformation, Neoplastic / genetics
  • Cell Transformation, Neoplastic / metabolism
  • Epidermal Growth Factor / pharmacology
  • Mice
  • Protein Kinase Inhibitors / pharmacology*
  • Proto-Oncogene Proteins c-akt / antagonists & inhibitors*
  • Proto-Oncogene Proteins c-akt / metabolism
  • Transcription Factor AP-1 / genetics
  • Transcription Factor AP-1 / metabolism
  • Xanthenes / pharmacology*

Substances

  • Antineoplastic Agents, Phytogenic
  • Protein Kinase Inhibitors
  • Transcription Factor AP-1
  • Xanthenes
  • norathyriol
  • Epidermal Growth Factor
  • Proto-Oncogene Proteins c-akt